R&D

News

Novavax begins late-stage trial of COVID-19 vaccine in the U...

Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK, which could support filings for a licence in the UK, EU and other countries.

News

UK gears up for 'challenge trial' of COVID-19 vaccine

The UK could be the first country to carry out a COVID-19 “challenge trial” where healthy volunteers are deliberately infected with coronavirus to test vaccines, according to press reports.

News

Political interference fears mount as Trump backs Pfizer's C...

President Donald Trump has suggested that Pfizer could be first to secure the first approval of a COVID-19 vaccine, as worries continue about political interference in the vaccine approval

News

Sanofi/Regeneron's Libtayo set for new skin cancer use

Sanofi and Regeneron plan to file their cancer immunotherapy Libtayo (cemiplimab) in a new indication following supportive findings from a phase 2 trial in a hard to treat group of skin can

News